From Quandary to Clarity in Relapsed/Refractory
Multiple Myeloma: Optimizing Treatment and
Empowering Patients A Three-Part Educational Series for Oncology Advanced Practitioners
Multiple myeloma (MM), a hematologic malignancy plagued by multiple relapses, has seen notable progress in care that has led to improved survival. Contributing to the progress has been an increased understanding of MM pathogenesis and cytogenetics-based risk stratification, and the availability of therapeutics such as immunomodulatory drugs, proteasome inhibitors, and novel targeted therapies. With the rapid pace of advances in MM, management of patients with relapsed/refractory (RR) disease is becoming increasingly complex. This educational initiative is designed to improve the ability of APs to provide high-quality care for patients with RRMM. It includes three expert clinical dialogues, downloadable slides, links to resources, and downloadable patient education materials.
Therapy for Relapsed/Refractory Multiple Myeloma (RRMM)—Optimizing Use of Current Options
Review how to optimize the use of current therapies, including incorporating risk-adapted treatment strategies and keeping up to date with evolving guidelines for evaluating treatment response.
Posted: July 31, 2019 / Expires: July 31, 2020
0.5 Credit
This certified activity has expired but you may watch the video without claiming credit.
Therapy for Relapsed/Refractory Multiple Myeloma (RRMM)—Preparing for Novel Agents
Discover the practice-changing implications of novel mechanisms of action, new combinations, and new administration options.
Posted: July 31, 2019 / Expires: July 31, 2020
0.5 Credit
This certified activity has expired but you may watch the video without claiming credit.
Enhancing Shared Decision Making in Relapsed/Refractory Multiple Myeloma (RRMM)
Learn how to incorporate patient-centered communication and shared decision making in your practice, thereby improving patient and caregiver adherence, satisfaction, and engagement.
Posted: July 31, 2019 / Expires: July 31, 2020
0.5 Credit
This certified activity has expired but you may watch the video without claiming credit.
These activities, certified for CME/CE/CPE credit, are jointly provided by
  |